MVA.HIVA

BIOLOGICAL5 trials

Sponsors

Medical Research Council, International AIDS Vaccine Initiative, Medical Research Council UK

Conditions

HIV InfectionsHIV-1HIV/AIDS Paediatrics

Phase 1

Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers

Medical Research CouncilHIV-1, HIV Infections

Start: 2009-11-30End: 2011-10-31Target: 72Updated: 2011-06-16

Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1/2-uninfected Mothers

CompletedNCT00982579

Medical Research CouncilHIV-1, HIV Infections

Start: 2009-11-30End: 2011-09-30Updated: 2012-02-03

Phase 2

A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected Volunteers

CompletedNCT01371175

International AIDS Vaccine InitiativeHIV Infections

Start: 2003-04-30Updated: 2011-06-10

Unknown Phase

Safety and immunogenicity of a candidate HIV-1 vaccine, MVA.HIVA, administered to healthy infants born to HIV-1/2-uninfected mothers.

Active, not recruitingPACTR2008120000904116

Medical Research Council UKHIV/AIDS Paediatrics

Start: 2009-12-15Target: 48Updated: 2026-09-14

Safety and immunogenicity of a candidate HIV-1 vaccine, MVA.HIVA, administered to healthy infants born to HIV-1/2-infected mothers.

Active, not recruitingPACTR2009010001152787

Medical Research Council UKHIV/AIDS Paediatrics

Start: 2010-02-01Target: 72Updated: 2026-09-14

Related Papers

A Phase I Randomized Clinical Trial of Candidate Human Immunodeficiency Virus type 1 Vaccine MVA.HIVA Administered to Gambian Infants

PLoS ONE2013-10-2420 citations